ICAM1 and breast cancer: It inhibits the cleavage of the NE extracellular substrates CD40 and ICAM‐1, downregulates NE‐induced ICAM‐1 gene expression, and inhibits the migration of highly invasive MDA‐MB‐231 breast cancer cells [289].